Ishihara Sangyo Kaisha (4028) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Nov, 2025Executive summary
Net sales for Q1 FY2025 were ¥37,595 million, nearly flat year-over-year, with operating income down 44.7% to ¥1,786 million and profit attributable to owners of parent down 42.3% to ¥2,873 million.
Comprehensive income decreased 29.4% year-over-year to ¥3,925 million.
Financial highlights
Gross profit declined to ¥8,892 million from ¥9,544 million year-over-year.
Ordinary income fell 28.7% to ¥4,136 million.
Net income per share was ¥75.24, down from ¥130.70 in the prior year.
Total assets increased to ¥231,019 million from ¥224,324 million at the end of March 2024.
Capital adequacy ratio was 46.4% as of June 30, 2024.
Outlook and guidance
Full-year net sales forecast is ¥144,000 million (+4.0% year-over-year), with operating income expected at ¥10,000 million (-13.0%) and profit attributable to owners of parent at ¥6,000 million (-24.9%).
Interim dividend forecast is ¥0.00, with year-end dividend forecast at ¥70.00 per share.
Management revised the financial results forecast during the period.
Latest events from Ishihara Sangyo Kaisha
- Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Net sales grew 10.4% year-over-year, but net income fell sharply by 80.6%.4028
Q2 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Net sales up 4.9% year-over-year, with profit and dividend growth forecast for FY2026.4028
Q4 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025 - Operating profit and net income surged, with robust outlook and higher full-year forecasts.4028
Q2 202620 Nov 2025